Dacikast-60 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Dacikast-60 mg Tablet contains daclatasvir, an NS5A-inhibitor direct-acting antiviral. Its labelling describes it for the treatment of chronic hepatitis C virus (HCV) infection. It is described as removing the virus from the blood over a certain time and lowering the load of hepatitis C virus. The doctor gives instructions on how to take it, including the duration, and the full course of treatment should be completed.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of chronic hepatitis C virus (HCV) infection
- Described as removing the virus from the blood over time
- Described as lowering the load of hepatitis C virus
Described Dosage & Administration
- Taken following the doctor’s instructions on dosage, duration, and interval
- Swallowed whole with or without food, at a fixed time; the tablet should not be broken, crushed, or chewed
- A missed dose is taken as soon as possible, but skipped if it is already time for the next dose; a double dose should never be taken
- The full course of treatment should be completed as instructed
Described Side Effects
Commonly described side effects include:
- Fatigue
- Headache
- Nausea
- Insomnia (difficulty sleeping)
- Anaemia (low number of red blood cells)
These are described as commonly temporary. The doctor should be consulted immediately if they persist or are bothersome.
Precautions
- The doctor should be notified about pregnancy, breastfeeding, or any other medications being taken
- The full course of treatment should be finished as instructed
- Any persistent side effect should be reported to the doctor
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains daclatasvir and is used for the treatment of chronic hepatitis C virus infection. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as swallowed whole with or without food at a fixed time, following the doctor’s instructions; a missed dose is not doubled and the full course should be completed.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.